Related Experiment Video
Updated: May 9, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Reversion and conversion of interferon-γ release assay results in HIV-1-infected individuals
Maximilian C Aichelburg1, Thomas Reiberger, Florian Breitenecker
1Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases (DIAID).
Abstract:
In this prospective study, human immunodeficiency virus type 1 (HIV-1)-infected subjects underwent QuantiFERON-TB Gold In-Tube interferon-γ release assay (IGRA) testing at baseline and after 24 months in a low tuberculosis incidence country. Concordant baseline and follow-up results were observed in 86% (n = 686 of 794) of subjects. IGRA conversions occurred in 9% (n = 63 of 718), whereas IGRA reversions were seen in 33% (n = 25 of 76) of individuals. Of the 10 active tuberculosis cases during follow-up, 5 had concordant positive IGRA results and 2 were IGRA converters. Although the clinical significance of IGRA conversions and reversions remains to be established, repeated IGRA testing seems to be of value in HIV-1-infected individuals.
Related Concept Videos
Size and Structure of Viral Genomes
Inhibitors of Viral Protein Synthesis

